250
Views
13
CrossRef citations to date
0
Altmetric
Original Research

Effect of aliskiren addition to amlodipine on ankle edema in hypertensive patients: a three-way crossover study

, , , , , & show all
Pages 1351-1358 | Published online: 22 Apr 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Scott S Billecke & Pamela A Marcovitz. (2013) Long-term safety and efficacy of telmisartan/amlodipine single pill combination in the treatment of hypertension. Vascular Health and Risk Management 9, pages 95-104.
Read now

Articles from other publishers (11)

Amanda J. Miller & Amy C. Arnold. (2018) The renin–angiotensin system in cardiovascular autonomic control: recent developments and clinical implications. Clinical Autonomic Research 29:2, pages 231-243.
Crossref
Nikolaos-Dimitrios Pantzaris, Evangelos Karanikolas, Konstantinos Tsiotsios & Dimitrios Velissaris. (2017) Renin Inhibition with Aliskiren: A Decade of Clinical Experience. Journal of Clinical Medicine 6:6, pages 61.
Crossref
Guido Grassi. (2016) Sympathomodulatory Effects of Antihypertensive Drug Treatment. American Journal of Hypertension 29:6, pages 665-675.
Crossref
Alexander R. Rosenkranz & Michaela Ratzinger. (2015) Efficacy, safety, and tolerability of antihypertensive therapy with aliskiren/amlodipine in clinical practice in Austria. The RALLY (Rasilamlo long lasting efficacy) study. Wiener klinische Wochenschrift 127:5-6, pages 203-209.
Crossref
Ayami Kajiwara, Junji Saruwatari, Ayana Kita, Kentaro Oniki, Masato Yamamura, Motoji Murase, Haruo Koda, Seisuke Hirota, Tadao Ishizuka & Kazuko Nakagawa. (2014) Younger Females Are at Greater Risk of Vasodilation-Related Adverse Symptoms Caused by Dihydropyridine Calcium Channel Blockers: Results of a Study of 11,918 Japanese Patients. Clinical Drug Investigation 34:6, pages 431-435.
Crossref
Y. Liu, R. Yan, A. Song, X. Niu, C. Cao, J. Wei, X. Dong & D. Gao. (2013) Aliskiren/Amlodipine vs. Aliskiren/Hydrochlorothiazide in Hypertension: Indirect Meta-Analysis of Trials Comparing the Two Combinations vs. Monotherapy. American Journal of Hypertension 27:2, pages 268-278.
Crossref
Giuseppe Derosa, Arrigo F. G. Cicero, Anna Carbone, Fabrizio Querci, Elena Fogari, Angela D’Angelo & Pamela Maffioli. (2013) RETRACTED ARTICLE: Different Aspects of Sartan + Calcium Antagonist Association Compared to the Single Therapy on Inflammation and Metabolic Parameters in Hypertensive Patients. Inflammation 37:1, pages 154-162.
Crossref
Michel Azizi & Joël Ménard. (2012) Renin Inhibitors and Cardiovascular and Renal Protection: An Endless Quest?. Cardiovascular Drugs and Therapy 27:2, pages 145-153.
Crossref
. (2012) Current World Literature. Current Opinion in Nephrology & Hypertension 21:5, pages 557-566.
Crossref
Gyu-Chul Oh, Hae-Young Lee, Hyun-Jae Kang, Joo-Hee Zo, Dong-Ju Choi & Byung-Hee Oh. (2012) Quantification of Pedal Edema During Treatment With S(-)-Amlodipine Nicotinate Versus Amlodipine Besylate in Female Korean Patients With Mild to Moderate Hypertension: A 12-Week, Multicenter, Randomized, Double-Blind, Active-Controlled, Phase IV Clinical Trial. Clinical Therapeutics 34:9, pages 1940-1947.
Crossref
Kazushi Tsuda. (2012) Renin-Angiotensin System and Sympathetic Neurotransmitter Release in the Central Nervous System of Hypertension. International Journal of Hypertension 2012, pages 1-11.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.